Mr Jeff McDaniel, the Faculty’s Director of Advancement (Medicine) and UQ Medical Endowment Director, is leaving to take up the position of Chief Development Officer with the Children’s Hospital Foundation.
Mr McDaniel has been with UQ for almost four years and leaves a strong legacy, having headed up a team that has raised substantial sums in philanthropic donations and endowments for medicine and biomedical research in the university.
UQ’s Faculty of Medicine and Biomedical Sciences’ Executive Dean Professor Nicholas Fisk said Mr McDaniel had brought a depth of experience from his previous positions in the USA, most recently in the health arena.
“Jeff’s commitment and dedication to raising the profile of this Faculty and that of the broader UQ community has been a valuable contribution to the university, specifically for health and medical research,” Professor Fisk said.
“In particular, he has enhanced returns to the University of co-leveraged donations.”
Mr McDaniel said that his time at UQ had been challenging, interesting and, above all, stimulating.
“It has been an absolute pleasure helping to raise money for medicine and biomedical research across UQ, working closely with world-class academics and helping to share my knowledge and love of philanthropy with my team and counterparts at other UQ faculties and institutes,” he said.
“The sort of success we have achieved in the past four years represents a team effort and wouldn’t have been possible without the contributions of many dedicated colleagues and the support of a few key clinical academics.”
Professor Fisk said that while the recruitment process was underway for a Faculty Director of Advancement, the Faculty’s advancement efforts would be overseen by UQ’s director of development and philanthropy, Mr Andrew Pentland.
The Faculty’s principal contact for advancement matters will be Josie Hackworth.
Professor Fisk also welcomed Ms Thea Kleiber to her new role as deputy Director of Advancement at the UQ Diamantina Institute.
He said Ms Kleiber would also be acting part-time in wider Faculty efforts, especially those focused on the Translational Research Institute and Princess Alexandra Hospital.
“Ms Kleiber comes to us from the USA, where she has recently worked in development roles in the health and education sectors,” Professor Fisk said.